MELANIE HIESTER: Open Payments
NPI 1689006256 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,526 in 165 payments from 19 companies in 2025. Trend: 2023 $1,815 · 2024 $2,158 · 2025 $2,526
Food & beverage: $2,526
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 20 | $373 |
| Bausch Health US, LLC | 38 | $361 |
| Alkermes, Inc. | 13 | $260 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $197 |
| Tris Pharma Inc | 17 | $197 |
| Novo Nordisk Inc | 10 | $185 |
| ABBVIE INC. | 14 | $162 |
| Axsome Therapeutics, Inc. | 8 | $142 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| Lundbeck LLC | 5 | $101 |
Products named: Jornay PM, APLENZIN, TRINTELLIX, Dyanavel XR, REXULTI, LYBALVI, Auvelity, VRAYLAR.
Industry payments across DE — which companies pay providers there.
